潜在的机制 潜在的治疗作用的治疗作用
Jinlong Zhao1,2,3, Guihong Liang1,2,3, Hetao Huang2
1The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
甘富士 (GFD) 通过多种成分和点治疗膝关节关节炎 (KOA),主要是通过调节炎症途径. 这项研究阐明了GFD治疗冷湿性阻塞类型KOA的复杂机制.
科学领域:
- 传统中国医药 传统中国医药
- 网络药理学 网络药理学
- 骨关节炎研究 骨关节炎研究
背景情况:
- 膝关节骨关节炎 (KOA) 用甘川富士 (GFD) 治疗缺乏清晰的活性成分和分子机制.
- 了解GFD在冷湿阻塞类型KOA中的作用对于优化治疗策略至关重要.
研究的目的:
- 研究甘川富士 (GFD) 在治疗冷湿阻塞综合征类型膝关节关节炎 (KOA) 的潜在机制.
- 利用网络药理学来阐明GFD在KOA治疗中的多组分,多目标相互作用.
主要方法:
- 使用传统中医药系统药理学 (TCMSP) 数据库对GFD草药 (富士,贵州,百州,甘) 的活性成分和选目标进行了选.
- 从CTD,GeneCards和DisGeNET等数据库中识别KOA目标,以找到常见的药物疾病目标.
- 使用Cytoscape和STRING构建了活性成分-标和蛋白质-蛋白质相互作用网络,然后通过DAVID.com进行GO和KEGG通路丰富分析.
主要成果:
- 确定了102个潜在的活性成分和208个与GFD治疗冷湿阻塞综合征类型KOA相关的目标.
- GFD对KOA的治疗作用与许多炎症信号通路的调节密切相关.
- 网络分析揭示了组件和目标的复杂相互作用,突出了GFD的整体方法.
结论:
- 甘富士 (GFD) 对冷湿阻塞综合征类型膝关节关节炎 (KOA) 产生治疗作用,通过一个复杂的机制,涉及多个组件,目标和途径.
- 这些发现为进一步实验验证GFD的药理动力学基础和作用机制提供了基础.
- 这项研究支持中国传统医学的复杂和多方面的性质,用于治疗像KOA这样的复杂疾病.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
12:24Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
相关概念视频
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Neurochemical Transmission: Sites of Drug Action
Elements Crucial for Effective Psychotherapy
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drugs Affecting Neurotransmitter Synthesis
